Log In
Print
BCIQ
Print
Print this Print this
 

ME-143 (formerly NV-143)

  Manage Alerts
Collapse Summary General Information
Company MEI Pharma Inc.
DescriptionDerivative of Triphendiol, a synthetic phenoxodiol analog
Molecular Target Tumor-associated NADH oxidase (tNOX) (ENOX2) (APK1) (COVA1)
Mechanism of ActionTumor-associated NADH oxidase (tNOX) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat refractory solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today